Partial structures are reported for Cav3.1 both on its own and in complex with a phase II drug candidate for seizure and neuropathic pain; this presents the overall architecture of T-type Ca2+ channels, insights into their gating and permeation mechanisms, and how they are modulated by small-molecule blockers.
- Yanyu Zhao
- Gaoxingyu Huang
- Nieng Yan